Close Menu

NEW YORK (360Dx) – Accelerate Diagnostics said after the close of the market on Tuesday that it had priced a $79.3 million public offering, consisting of 2.75 million shares of its common stock at a price of $28.85 per share, after originally offering 2.5 million shares.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.